Observational Study on the Efficacy, Safety, and Tolerability of GAlcanezumab in Real Life Migraine Patients in ITaly

NCT04803513 · clinicaltrials.gov ↗

UNKNOWN

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Migraine

Interventions

DRUG: Galcanezumab

Sponsor

Campus Bio-Medico University